Otros idiomas electroCore, Inc.

Acciones

ECOR

US28531P2020

Mercado cerrado - Nasdaq Otros sitios de cotización 22:00:00 26/04/2024			Varia. Cinco días.	Varia. 1 de enero.
5,76 ^USD	+1,95 %		+1,95 %	-3,22 %

08/04	ElectroCore, Inc. anuncia el lanzamiento de Truvaga Plus® para el bienestar general	CI
13/03	ElectroCore, Inc. Resultados del ejercicio cerrado el 31 de diciembre de 2023	CI

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

ElectroCore Announces the Launch of Truvaga Plus® for General Wellness	08/04
ElectroCore, Inc. Announces the Launch of Truvaga Plus® for General Wellness	08/04
ElectroCore Expands Intellectual Property Portfolio	02/04
ElectroCore, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	13/03
ElectroCore, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	13/03
Earnings Flash (ECOR) ELECTROCORE Posts Q4 Revenue $5.2M, vs. Street Est of $5M	13/03
ElectroCore Announces Fourth Quarter and Full Year 2023 Financial Results	13/03
ElectroCore to Participate in Upcoming Investor Conferences	12/03
ElectroCore to Announce Fourth Quarter and Full Year Ended December 31, 2023 Financial Results on Wednesday, March 13, 2024	05/03
ElectroCore Expands Intellectual Property Portfolio	06/02
Certain Common Stock of electroCore, Inc. are subject to a Lock-Up Agreement Ending on 28-JAN-2024.	28/01
Certain Warrants of electroCore, Inc. are subject to a Lock-Up Agreement Ending on 28-JAN-2024.	28/01
Certain Options of electroCore, Inc. are subject to a Lock-Up Agreement Ending on 28-JAN-2024.	28/01
Ondine Biomedical appoints Joseph Errico as new CFO	16/01
ElectroCore Expands Intellectual Property Portfolio	09/01
ElectroCore Says Two US Patents Issued for Non-Invasive Vagus Nerve Stimulation Technology	26/12
ElectroCore Expands Intellectual Property Portfolio	26/12
ElectroCore, Inc. Appoints Charles S. Theofilos as New Class Iii Member of the Board	14/12
ElectroCore Expands Intellectual Property Portfolio for Nerve Stimulation Technology	12/12
Dr. Peter Staats to Host Analyst Day on the Science Behind gammaCore™ Non-Invasive Vagus Nerve Stimulation (nVNS) on Tuesday, November 21, 2023	15/11

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas electroCore, Inc.

Acciones

ECOR

US28531P2020

Otros idiomas

Filtros